Market Movers: DAX40 & DOW JONES Weekly Analysis Embracing the Volatility This past week has been a rollercoaster ride for investors as the markets closed in the red. The record natural gas prices reaching above €300/MWh and the economic conference in Jackson Hole, Wyoming have left many feeling on edge. Fed Chairman Jerome Powell’s speech…
Rising AR/VR Smart Glasses Uses in Forward-Thinking Businesses New York, US, Aug. 25, 2022 (GLOBE NEWSWIRE) According to a comprehensive research report by Market Research Future (MRFR), “AR and VR Smart Glasses Market Analysis by Device Type, Product, Application – Forecast till 2030” valuation is poised to reach USD 25.8 Billion by 2030, registering a……
Welcome to Jaybee’s Chicken Palace! New Addition to Amergent Hospitality Group CHARLOTTE, N.C., Aug. 23, 2022 (GLOBE NEWSWIRE) — Amergent Hospitality Group (OTCQB:AMHG) (“Amergent” or the “Company”), owner, operator and franchisor of multiple nationally-recognized restaurants, today announced the launch of Jaybee’s Chicken Palace in Portland, Oregon. Hatched from the former Waddle’s landmark location on Jantzen…
Charmingly Eccentric: The Impact of Current Market Trends on Currency Exchange EUR/USD Dips Ahead of PMI Data Release EUR/USD is now trading down by 0.4% to near 0.9900 and that is even before we get to the PMI data in Europe later today. This comes as the dollar is seen pulling higher with GBP/USD also…
Welcome to Our Blog Post An Insightful Look at Assertio Holdings, Inc. August 22, 2022 Today, we would like to discuss the recent announcement made by Assertio Holdings, Inc. regarding the pricing of its offering of $60 million aggregate principal amount of 6.50% convertible senior notes due 2027. This news signifies a significant move for…
Vyant Bio Announces Rescheduled Investor Conference Call and Web… CHERRY HILL, N.J., Aug. 19, 2022 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (“CNS”) drug discovery platform combines human-derived organoid models…
OMNIQ Corp CEO to present at Rosenblatt Securities 2nd Annual Technology Summit What to expect from the presentation? OMNIQ Corp, a leader in Supply Chain and Artificial Intelligence solutions, will have key members of its management team participate in the Rosenblatt Securities 2nd Annual Technology Summit: The Age of AI Scaling. During the summit, the…
Welcome to the World of Kapruvia®: The Game-Changer in CKD-Associated Pruritus Treatment What is Kapruvia®? Kapruvia® (difelikefalin) has recently made waves in the medical world as the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients. This groundbreaking therapy has been approved in Switzerland…
